US to slash prices of obesity drugs offered on Trump website
White House’s landmark deal with Novo Nordisk and Eli Lilly will cut costs from at least $1,000 to about $350
Related reading
Weight-loss weariness and Trump threats wipe $250bn off Novo Nordisk and Eli…
Trump’s push for price cuts and tariffs weighs on ‘obesity franchises’, which have missed out on equity market’s rise
Trump administration slashes Ozempic and Wegovy price for Medicare
US negotiates 71% cost reduction of Novo Nordisk’s obesity drugs for elderly Americans on government health insurance
White House launches TrumpRx as drug companies warn of sales hit
Platform offers discounts for weight-loss and fertility medicines sold by Novo Nordisk, Eli Lilly and others
Novo Nordisk shares slide as Trump vows to cut Ozempic price
US administration is in negotiations over cost of Danish group’s best-selling obesity drug
UK patients rush to buy obesity jab ahead of 170% price rise
Asda warns of ‘difficult situation’ after US drugmaker Eli Lilly responds to pressure from Donald Trump
Sandoz targets 70% price cut for weight-loss drugs in Canada
Generic drugmaker is preparing cheaper alternatives for when patents expire in the country next year